Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study

BMJ Open
Manuj SharmaIrene Petersen

Abstract

To investigate trends in incident and prevalent diagnoses of type 2 diabetes mellitus (T2DM) and its pharmacological treatment between 2000 and 2013. Analysis of longitudinal electronic health records in The Health Improvement Network (THIN) primary care database. UK primary care. In total, we examined 8,838,031 individuals aged 0-99 years. The incidence and prevalence of T2DM between 2000 and 2013, and the effect of age, sex and social deprivation on these measures were examined. Changes in prescribing patterns of antidiabetic therapy between 2000 and 2013 were also investigated. Overall, 406,344 individuals had a diagnosis of T2DM, of which 203,639 were newly diagnosed between 2000 and 2013. The incidence of T2DM rose from 3.69 per 1000 person-years at risk (PYAR) (95% CI 3.58 to 3.81) in 2000 to 3.99 per 1000 PYAR (95% CI 3.90 to 4.08) in 2013 among men; and from 3.06 per 1000 PYAR (95% CI 2.95 to 3.17) to 3.73 per 1000 PYAR (95% CI 3.65 to 3.82) among women. Prevalence of T2DM more than doubled from 2.39% (95% CI 2.37 to 2.41) in 2000 to 5.32% (95% CI 5.30 to 5.34) in 2013. Being male, older, and from a more socially deprived area was strongly associated with having T2DM, (p<0.001). Prescribing changes over time reflected e...Continue Reading

References

Apr 28, 1990·BMJ : British Medical Journal·J Chisholm
Aug 10, 2000·Drugs·J M Chehade, A D Mooradian
Jun 7, 2007·The New England Journal of Medicine·David M Nathan
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Sep 26, 2008·Diabetologia·B CarstensenUNKNOWN Steering Group of the National Diabetes Register
Dec 10, 2008·Pharmacoepidemiology and Drug Safety·Andrew MaguireMary Thompson
Feb 25, 2009·Expert Opinion on Drug Safety·C V RizosE N Liberopoulos
Feb 26, 2009·Journal of Epidemiology and Community Health·E L Massó GonzálezL A García Rodríguez
May 21, 2009·Pharmacoepidemiology and Drug Safety·Shreya Davé, Irene Petersen
May 4, 2010·Public Health Reports·Sharon Saydah, Kimberly Lochner
Aug 10, 2010·Clinical Pharmacokinetics·André J Scheen
Nov 6, 2012·Pharmacoepidemiology and Drug Safety·Laura HorsfallIrene Petersen
May 17, 2013·Diabetes, Obesity & Metabolism·S H HoldenC J Currie
Jan 1, 2014·Pharmacoepidemiology and Drug Safety·Ronac MamtaniJames D Lewis
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Caroline Kaercher KramerRavi Retnakaran
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw
Apr 2, 2014·Expert Opinion on Drug Safety·Sheila A Doggrell, Simon B Dimmitt
Jun 22, 2014·Archives of Pharmacal Research·Go Woon Kim, Sung Hyun Chung
Jun 3, 2015·BMJ Open·Maria E GoossensFrank de Vries

❮ Previous
Next ❯

Citations

Jul 26, 2016·Frontiers in Endocrinology·Flávia de Toledo FriasAlice Cristina Rodrigues
Aug 1, 2016·Canadian Journal of Diabetes·Hossein EbrahimiAkbar Fotouhi
Jul 29, 2016·Diabetologia·Stephanie H ReadUNKNOWN Scottish Diabetes Research Network Epidemiology Group
Feb 9, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·S E HoldenC J Currie
May 20, 2017·International Journal of Clinical Practice·Manuel Enrique Machado-DuqueJorge Enrique Machado-Alba
Apr 8, 2017·Diabetes, Obesity & Metabolism·Salwa S ZghebiDarren M Ashcroft
May 17, 2017·Diabetes, Obesity & Metabolism·Adrian BrownGary Frost
Feb 15, 2018·Diabetes Care·Céline VetterFrank A J L Scheer
Feb 20, 2018·Diabetes, Obesity & Metabolism·Stephanie Claire BridgemanCyril Desire Sylvain Mamotte
Feb 21, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·T P CandlerJ P H Shield
Apr 11, 2018·International Journal of Technology Assessment in Health Care·Ricardo Saad HenriquesAstrid Wiens
May 15, 2018·The Journal of Clinical Investigation·Mitchell A Lazar
May 8, 2018·Diabetes, Obesity & Metabolism·Helen J CurtisBen Goldacre
Jul 28, 2018·Diabetes/metabolism Research and Reviews·Bettina HartmannReinhard W Holl
Sep 8, 2017·BMJ Open Diabetes Research & Care·Segundo Nicolas SeclenCecilia Alexandra Medina
Nov 25, 2018·Diabetes, Obesity & Metabolism·Ruth L M Cordiner, Ewan R Pearson
Jun 14, 2019·Post Reproductive Health·John C Stevenson
Aug 7, 2019·Journal of Cellular Biochemistry·Madison E RiveraRoger A Vaughan
Sep 3, 2019·European Journal of Clinical Pharmacology·Jisu KimNam Kyung Je
Dec 4, 2019·Diabetes, Obesity & Metabolism·Silvio E InzucchiUNKNOWN EMPA-REG OUTCOME® Investigators
Aug 12, 2017·JBI Database of Systematic Reviews and Implementation Reports·Jared M CampbellEdoardo Aromataris
Mar 4, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·J RouetteL Azoulay
Jul 30, 2018·BMJ Open·Samantha WilkinsonLaurie Tomlinson
May 16, 2020·Journal of the American Heart Association·Joht Singh ChandanKrishnarajah Nirantharakumar

❮ Previous
Next ❯

Software Mentioned

THIN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved